Abstract:AbstractBackgroundAlzheimer’s disease (AD) is a progressive and debilitating neurological disorder that impacts millions of individuals globally. Prompt and accurate detection and diagnosis of Alzheimer’s disease are pivotal for providing effective care and management to patients. However, early identification of the disease remains challenging due to the complexity of diagnostic procedures and the similarity of symptoms with age‐related cognitive decline. With the world transitioning towards a more digital‐focused environment, there is an increasing potential to utilize human‐computer interaction technologies to aid in the early detection of Alzheimer’s disease.MethodWe recruited 40 healthy individuals, 40 patients with mild cognitive impairment (MCI), and 40 patients with early AD. By incorporating fusion perception‐enhancing technologies into intelligent identification devices, such as eye‐tracking and body motion detection, peripheral modal biometric information can be gathered from subjects.ResultThe study found that in human‐computer interaction experiments using eye‐tracking, the patients with early AD showed significantly longer completion times and free rates of eye motion and movement trajectory than the normal group and those with MCI. The correlation between eye motion trajectory and movement trajectory was notably lower as compared to the normal group and the MCI group. During the human‐computer interaction physical movement experiment, the AD group recorded lower target accuracy rate and screen click rate as compared to the normal group and patients with MCI. Similarly, in the human‐computer interaction clock drawing experiment, the AD group demonstrated longer completion time and pen‐up thinking time, as well as lower clock drawing scores. Furthermore, the total completion time of human‐computer interaction tasks was notably shorter as compared to conventional cognitive screening tests. In conclusion, peripheral biomarkers obtained from the aforementioned human‐computer interaction task were analyzed using machine learning techniques, resulting in the identification of early‐stage Alzheimer’s disease with a classification accuracy of 91.1%.ConclusionHence, this non‐invasive and accurate technique may prove instrumental in identifying potential cognitive deficits associated with this disease while also being widely applicable for screening early AD.

Innovative diagnostic tools for early detection of Alzheimer's disease

Digitized Biomarkers Utilizing Human‐Computer Interaction Sensing Technology for Early Auxiliary Diagnosis of Alzheimer’s Disease

Early Detection of Alzheimer’s disease by using the Latest Techniques

Blood-Based Biomarkers for Early Alzheimer's Disease Diagnosis in Real-World Settings

Progress on early diagnosing Alzheimer's disease

Novel techniques for early diagnosis and monitoring of Alzheimer's disease

Emerging Biomarkers for Early Detection of Alzheimer's Disease: A Systematic Review

Biomarkers and Tools for Predicting Alzheimer's Disease in the Preclinical Stage

Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies

Advances in screening instruments for Alzheimer's disease

Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease

Early Diagnosis of Alzheimer’s Disease: Moving Toward a Blood-Based Biomarkers Era

Detection and treatment of Alzheimer’s disease in its preclinical stage

Advancing Non-Invasive Diagnostics and Prognostics

Increasing Precision of Clinical Diagnosis of Alzheimer's Disease Using a Combined Algorithm Incorporating Clinical and Novel Biomarker Data

Biomarkers for Alzheimer’s Disease Early Diagnosis

Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI)

An Algorithm for Preclinical Diagnosis of Alzheimer's Disease

Alzheimer's disease biomarkers and their current use in clinical research and practice

Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease

Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future